BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37776851)

  • 1. Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis.
    Tsioras K; Smith KC; Edassery SL; Garjani M; Li Y; Williams C; McKenna ED; Guo W; Wilen AP; Hark TJ; Marklund SL; Ostrow LW; Gilthorpe JD; Ichida JK; Kalb RG; Savas JN; Kiskinis E
    Cell Rep; 2023 Oct; 42(10):113160. PubMed ID: 37776851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
    Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
    Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS.
    Hall CE; Yao Z; Choi M; Tyzack GE; Serio A; Luisier R; Harley J; Preza E; Arber C; Crisp SJ; Watson PMD; Kullmann DM; Abramov AY; Wray S; Burley R; Loh SHY; Martins LM; Stevens MM; Luscombe NM; Sibley CR; Lakatos A; Ule J; Gandhi S; Patani R
    Cell Rep; 2017 May; 19(9):1739-1749. PubMed ID: 28564594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
    Luisier R; Tyzack GE; Hall CE; Mitchell JS; Devine H; Taha DM; Malik B; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Nat Commun; 2018 May; 9(1):2010. PubMed ID: 29789581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream Effects of Mutations in
    Dash BP; Freischmidt A; Weishaupt JH; Hermann A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vcp overexpression and leucine supplementation extend lifespan and ameliorate neuromuscular junction phenotypes of a SOD1G93A-ALS mouse model.
    Huang TN; Shih YT; Yen TL; Hsueh YP
    Hum Mol Genet; 2024 May; 33(11):935-944. PubMed ID: 38382647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
    Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
    Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.
    Chen H; Qian K; Du Z; Cao J; Petersen A; Liu H; Blackbourn LW; Huang CL; Errigo A; Yin Y; Lu J; Ayala M; Zhang SC
    Cell Stem Cell; 2014 Jun; 14(6):796-809. PubMed ID: 24704493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
    Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
    Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons.
    Namboori SC; Thomas P; Ames R; Hawkins S; Garrett LO; Willis CRG; Rosa A; Stanton LW; Bhinge A
    Stem Cell Reports; 2021 Dec; 16(12):3020-3035. PubMed ID: 34767750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS.
    Günther R; Pal A; Williams C; Zimyanin VL; Liehr M; von Neubeck C; Krause M; Parab MG; Petri S; Kalmbach N; Marklund SL; Sterneckert J; Munch Andersen P; Wegner F; Gilthorpe JD; Hermann A
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration.
    Tung YT; Peng KC; Chen YC; Yen YP; Chang M; Thams S; Chen JA
    Cell Stem Cell; 2019 Aug; 25(2):193-209.e7. PubMed ID: 31155482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations.
    Kim BW; Jeong YE; Wong M; Martin LJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):7. PubMed ID: 32005289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Insights of Astrocyte-Mediated Hyperactive Autophagy and Loss of Motor Neuron Function in SOD1
    Rajpurohit CS; Kumar V; Cheffer A; Oliveira D; Ulrich H; Okamoto OK; Zatz M; Ansari UA; Khanna VK; Pant AB
    Mol Neurobiol; 2020 Oct; 57(10):4117-4133. PubMed ID: 32676988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous treatment for ALS with implication for broad neuroprotection.
    Kim D; Kim S; Sung A; Patel N; Wong N; Conboy MJ; Conboy IM
    Transl Neurodegener; 2022 Mar; 11(1):16. PubMed ID: 35272709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motoneuronal and muscle-selective removal of ALS-related misfolded proteins.
    Crippa V; Galbiati M; Boncoraglio A; Rusmini P; Onesto E; Giorgetti E; Cristofani R; Zito A; Poletti A
    Biochem Soc Trans; 2013 Dec; 41(6):1598-604. PubMed ID: 24256261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.